A major Japanese pharmaceutical company acquired a Middle East Israeli venture company developing therapeutic agents for Parkinson's disease for about 120 billion yen, The president who visited the site said that he would like to strengthen the business in the United States which is the world's largest pharmaceutical market by the acquisition.